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Osteogenesis imperfecta is a clinically and genetically heterogeneous brittle bone disorder that results from defects in the synthesis,
structure, or posttranslational modiﬁcation of type I procollagen. Dominant forms of OI result from mutations in COL1A1 or
COL1A2, which encode the chains of the type I procollagen heterotrimer. The mildest form of OI typically results from diminished
synthesis of structurally normal type I procollagen, whereas moderately severe to lethal forms of OI usually result from structural defects
in one of the type I procollagen chains. Recessively inherited OI, usually phenotypically severe, has recently been shown to result from
defects in the prolyl-3-hydroxylase complex that lead to the absence of a single 3-hydroxyproline at residue 986 of the a1(I) triple helical
domain. We studied a cohort of ﬁve consanguineous Turkish families, originating from the Black Sea region of Turkey, with moderately
severe recessively inherited OI and identiﬁed a novel locus for OI on chromosome 17. In these families, and in a Mexican-American
family, homozygosity for mutations in FKBP10, which encodes FKBP65, a chaperone that participates in type I procollagen folding,
was identiﬁed. Further, we determined that FKBP10 mutations affect type I procollagen secretion. These ﬁndings identify a previously
unrecognized mechanism in the pathogenesis of OI.Introduction
Osteogenesis imperfecta (OI [MIM 166200, 166210,
259420, 166220, 610967, 61098, 610682, 610915,
259440]) is a heritable brittle bone disease that varies in
severity frommild to neonatal lethal. In addition to clinical
heterogeneity, there is genetic heterogeneity with auto-
somal-dominant and -recessive forms of the disease. The
vast majority of individuals with OI have dominantly in-
herited mutations in COL1A1 or COL1A2 (MIM 120150,
120160) that encode type I procollagen and result in defects
in the synthesis or structure of type I collagen.1 OI has been
historically classiﬁed into subtypes primarily based on
clinical and, recently, molecular ﬁndings. Individuals with
OI type I, the mildest phenotype, have normal or near-
normal height and the phenotype usually results from
mutations that lead to decreased synthesis of structurally
normal type I collagen. The more severe OI types (II–IV)
typically result from mutations that lead to structural
defects in type I collagen.2 Less common forms include OI
typeV,3 anautosomal-dominant formofunknownetiology
withhypertrophic callus formation, densemetaphyses, and
a mesh-like histological appearance of the bone; OI type1Pediatric Genetics Unit, Department of Pediatrics, Hacettepe University Me
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The AmVI,4 a moderately severe, recessively inherited type of
unknown cause that includes increased serum alkaline
phosphatase (ALP) levels and bone histology described as
exhibiting a ﬁsh scale-like lamellar pattern; and OI type
VII,moderately severe, recessively inherited forms resulting
from decreased expression of the cartilage associated
protein (CRTAP) (MIM 605497) gene.5,6
Type I procollagen, a heterotrimer composed of two a1(I)
and one a2(I) chains, is assembled in the lumen of the
endoplasmic reticulum (ER). The three chains associate
noncovalently at their carboxyl termini, with chain selec-
tion determined by the C-terminal propeptides. Disulﬁde
bonds form between the chains, mediated by protein-
disulﬁde isomerase (PDI). The unfolded chains undergo
several posttranslational modiﬁcations including 4-prolyl
hydroxylation, which is a critical modiﬁcation for in-
creasing the stability of the folded protein. Additional
modiﬁcations include 3-hydroxylation of proline residue
986 of the a1(I) triple helical domain, which is accom-
plished by the prolyl-3-hydroxylase complex,5 and
hydroxylation of some lysine residues by lysyl hydroxy-
lases, followed by glycosylation by collagen galactosyl-
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BiP, and HSP47, assist with proper chain registration and
folding of the molecules into the collagen triple helix.8
Once the chains fold, they are inaccessible to further post-
translational modiﬁcation.9 The triple helical procollagen
molecules leave the ER, trafﬁc to the Golgi, and are then
packaged into secretory vesicles and released into the
extracellular matrix. They are then processed by removal
of the amino- and carboxy-terminal propeptides and
form the substrate for bone mineralization.10
Recently, the importance of the processes involved in
type I collagen posttranslational modiﬁcation in OI has
been uncovered. Morello et al.5 showed in a knockout
mouse model that cartilage associated protein (CRTAP) is
essential for prolyl-3-hydroxylation and that reduced or
absent activity leads to OI. CRTAP is part of the collagen
prolyl-3-hydroxylase complex along with prolyl-3-hydrox-
ylase-1 (P3H1 [MIM 610339]) and cyclophilin B or pep-
tidyl-prolyl isomerase B (CYPB or PPIB [MIM 123841])
in a 1:1:1 ratio.11 Mutations in LEPRE1, which encodes
P3H1, have also been shown to be associated with reces-
sively inherited severe OI.5,6,12 In a subsequent study, Bal-
dridge et al.13 screened a cohort of 78 individuals with
presumed recessive forms of OI and found mutations in
either CRTAP or LEPRE1 in 19 individuals. The absence
of mutations in most cases suggests that there are addi-
tional genes responsible for recessive OI that have yet to
be discovered.
We ascertained and studied ﬁve families that originated
fromNorthern Turkeywith a severe, progressive deforming
type of OI. In these families, autosomal-recessive epider-
molysis bullosa simplex (EB [MIM 131900]), resulting
from a defect in keratin 14, cosegregated with the progres-
sive, deforming OI.14 Homozygosity by descent mapping
demonstrated that all affected individuals shared a 0.83
Mb region on chromosome 17q21 containing KRT14, the
gene that encodes keratin 14. Sequence analysis of genes
in the interval revealed that the OI phenotype resulted
from homozygosity for an in-frame deletion in FKBP10,
the gene that encodes the immunophilin FKBP65 (MIM
607063). In a second OI family, homozygosity for an
FKBP10 null mutation was identiﬁed. FKBP65 has been
shown to interact with type I collagen and tropoelastin,
and we demonstrate that FKBP65 mutations affect the
secretion of type I collagen. Thus, in addition to defects
leading to alterations in the structure, synthesis, and post-
translational modiﬁcation of type I procollagen, loss of
FKBP65 chaperone activity can also produce a progressive
deforming OI phenotype.Material and Methods
Clinical Information, DNA Isolation, and Genotyping
Patients and their family members were assessed under approved
human subjects protocols and all participants provided informed
consent. Clinical information, radiographs, serum alkaline phos-
phatase levels, and skin and bone histology were reviewed to
determine the ﬁndings in the affected individuals. DNA was552 The American Journal of Human Genetics 86, 551–559, April 9, 2isolated from either blood or cultured ﬁbroblasts via a standard
manufacturer’s protocol (QIAGEN). Genotypes were determined
with the GeneChip Mapping 250K array set and standard proto-
cols (Affymetrix), and SNPs surrounding KRT14 on chromosome
17q21 were analyzed with a standard bioinformatics package
(Vigenos, Hemosoft).
Bone Immunohistochemistry
Bone biopsies from the iliac crest of patient R06-116A were
obtained during surgery to correct severe scoliosis. Biopsy speci-
mens were ﬁxed in 10% buffered formalin and processed for
parafﬁn embedding after decalciﬁcation. Decalciﬁed 6-mm-thick
sections were cut and stained with Masson trichrome and tolui-
dine blue (pH 3.7). Bone tissue obtained from the autopsy of an
age-matched patient was used as a control. Sections were visual-
ized under polarized light at 2003 magniﬁcation.
Mutation Detection for KRT14 and FKBP10
and RT-PCR
With 50 ng of genomic DNA per reaction, exon 3 of KRT14
(Ensembl; ENSG0000018684) and the ten coding exons of
FKBP10 (Ensembl: ENSG00000321562) were ampliﬁed by PCR
(oligonucleotide sequences and conditions are available upon
request). Nucleotide sequences of the PCR products were deter-
mined by bidirectional sequence analysis (MC Labs) and
compared with the reference sequence for KRT14 and FKBP10
via Sequencher (Gene Codes). Nucleotides were numbered start-
ing from the A of the ATG initiation codon. Fibroblasts were prop-
agated in DMEM with 10% fetal bovine serum (FBS). RNA was
isolated with Trizol (Invitrogen) and RT-PCR for FKBP10 was
performed via SuperScript III (Invitrogen) with oligonucleotides
that spanned introns 8 and 9.
Cell Culture and Analysis of Collagenous Proteins
Dermal ﬁbroblast cultures were established from explanted skin
biopsies from three OI patients (International Skeletal Dysplasia
Registry reference numbers R06-113A from family 2, R06-016
from family 3, and R93-188A and R93-188B from family 6). Fibro-
blasts from affected individuals and controls were plated at
conﬂuence (250,000 cells) in 35 mm tissue culture dishes in Dul-
becco-Vogt Modiﬁed Eagle Medium supplemented with 10% FBS
allowed to attach overnight, and then incubated in the presence
of 50 mM ascorbic acid for 18 hr prior to labeling. For pulse-chase
studies, conﬂuent cells were starved of proline in serum-free
medium supplemented with 50 mM ascorbic acid for 1 hr, then
labeled in serum-free medium with 100 mCi/ml [2,3,4,5-3H]
proline. After 60 min in label, cells were rinsed twice with
complete medium with 50 mM ascorbic acid, and fresh chase
medium was added that contained 12 mM proline as previously
described.15 At 0, 20, 40, 60, and 120 min, the medium was dec-
anted and the cell layer scraped into a separate tube in PBS.
Protease inhibitors were added to both, and the collagenous
proteins were precipitated with 50% v:v ethanol and carrier
collagen in the presence of 15 mM iodoacetamide added to
prevent new disulﬁde bond formation. Precipitated proteins were
resuspended in SDS-sample buffer and separated on 5% SDS-PAGE
under nonreducing conditions.15 All gels were ﬁxed, treated with
Enhance, and dried. Radiolabeled bands were visualized by auto-
radiography and densities were quantiﬁed with Image J.
3-hydroxylation of proline at position 986 of the triple helix in
the a1(I) chains of type I collagen was determined on collagen010
Family1
Family 2
Family 3
Family 4
Family 5
Family 6
I I I
I
I
II
III
IV
V
VI
VIII
VII
II
III
IV
II
III
IV
II
II
III
IV
V
VI
1 2
1 2 4 5 6
1 2 3 4 5 6
6 7 8 91 2 3 4 5
1 2 3 4 5 6 7 8 9
1 2 3 4 5 6
1 2
1 2 3 4
5 6
7 8 9
11
11 12
10
10
9
987654
4 1211109876532
2
1
1
1
1
1 2 3 4
2 3 4 5 6
2 3 4 5 6 7 8
3
1 2
1
1
1
1
1
1
1
1
1
1
2 2
2 2
2
2
2
3
3
4
4 5 6 7 8
3
Figure 1. Pedigrees of OI Families
Turkish OI families originating from the Black Sea region of Turkey (Families 1–5) and the Mexican-American OI family (Family 6).prepared from cell cultures of skin ﬁbroblasts. Either CNBR-
derived peptides or pepsinized collagens were isolated by SDS-
PAGE and tryptic digests prepared for MS/MS. Electrospray MS
was performed on an LCQ Deca XP ion-trap mass spectrometer
with in-line liquid chromatography (LC) (ThermoFinnigan)
with a C8 capillary column (300 mm 3 150 mm; Grace Vydac
208MS5.315) eluted at 4.5 ml/min. The mobile gradient was
made from buffer A (0.1% formic acid plus 2% buffer B in MilliQ
water) and buffer B (0.1% formic acid in 3:1 acetonitrile:n-propa-
nol v/v). An electrospray ionization source (ESI) under atmo-
spheric pressure was used to introduce the sample stream into
the mass spectrometer. The spray voltage was 3 kV and the inlet
capillary temperature 160C.
Transmission Electron Microscopy
Cells were ﬁxed in 2% glutaraldehyde, 2% paraformaldehyde in
0.1 M sodium cacodylate buffer and washed. After postﬁxation
in 1%OsO4 in buffer for 1 hr, the cells were dehydrated in a graded
series of ethanol, treated with propylene oxide, and embedded in
Eponate 12 (Ted Pella). Thin sections (60 nm) were cut, placed on
formvar-coated grids, and counterstained with 7% methanolic
uranyl acetate and lead citrate. Sections were viewed with a Tecnai
12 transmission electron microscope at 120 kV and images were
digitally captured.
Immunohistochemistry
Cultured ﬁbroblasts were seeded on 4-well chamber slides (Lab-
Tek) and grown in 10% FBS to near conﬂuence. Slides were washed
with ice-cold PBS and ﬁxed in 4% paraformaldehyde for 15 min atThe Amroom temperature. Cells were permeabilized with PBS plus 0.1%
Tween-20 (PBST), blocked with 10% goat serum (Zymed) for
1 hr, and incubated with the following antibodies: msFKBP65
(BD), type I procollagen, LF41 (a kind gift from Dr. L.W. Fisher,
National Institutes of Health), diluted 1/50, 1/25, and 1/50,
respectively, in 1% goat serum/PBST overnight at 4C. Primary
antibodies were detected with either Alexa Fluor 488 or 568 and
goat anti-mouse antibody (Molecular Probes, Invitrogen) diluted
1/400 in 1% goat serum/PBST at room temperature for 1 hr. Slides
were coverslipped with Vectashield with DAPI. Confocal images
were taken sequentially on a Leica TCS-SP2 AOBS inverted
Confocal Microscope (Mannheim) equipped with a 405 nm blue
diode laser, argon laser (488 nm blue excitation: JDS Uniphase),
and three helium neon lasers (543 nm, green; 594 nm, near red;
633 nm, far red excitations).Results
OI Clinical Findings and Bone Histology
Affected individuals from ﬁve separately ascertained
Turkish families had clinically normal consanguineous
parents (Figure 1). These families originated from neigh-
boring cities about 120 km apart in the Black Sea region
of Turkey. A geneological link was established between
two small nuclear families (Families 1 and 2, Figure 1),
whereas the remaining three families declared no relation-
ship. All affected individuals had normal birth length anderican Journal of Human Genetics 86, 551–559, April 9, 2010 553
Figure 2. Clinical Phenotype
(A) EB at the ankle (arrow) in case
R06-113A.
(B) Upper extremity joint laxity and long
ﬁngers in R06-113A.
(C and D) Radiographs showing scoliosis
(arrows) in R06-113A and R93-188A,
respectively.
(E and F) Wedge vertebrae (arrows) in
R06-113A and R93-188A, respectively.
(G and H) Fractures, bent bones, and
osteopenia (arrows) in R06-113A.
Figure 3. Bone Histomorphology
Bone histology from the iliac crest from control and an affected
individual (R06-113A) demonstrating normal (A) and abnormal
(B) lamellar bone patterns (arrows).weight but were born with skin blisters on their hands and
feet, which later developed into generalized bullous lesions
(Figure 2). Epidermolysis bullosa (EB) simplex was diag-
nosed and histologically conﬁrmed by absence of keratin
14 (data not shown).
All affected individuals had a history of recurrent long
bone fractures, beginning in infancy, which led to severe
deformities in the extremities, and they were wheelchair
bound by early childhood. Progressive kyphoscoliosis
developed during childhood and some of the patients
underwent corrective spinal surgery. Radiographic evalua-
tion demonstrated severe osteopenia, fractures leading to
deformities in the long bones, and kyphoscoliosis with
ﬂattening and wedging of the vertebrae (Figure 2). None
of the affected individuals had dentinogenesis imperfecta,
their sclerae were grayish white, not blue, and hearing was
normal. Ligamentous laxity with long ﬁngers and toes was
noted in two patients. Elevated alkaline phosphatase levels
were detected in two of the ascertained individuals at ages
6 and 16, respectively (levels were 300 IU and 400 IU,
normal < 100 IU). All of the affected individuals ascer-
tained had both OI and EB and, in extended pedigree
analysis (Figure 1), there were no historically reported
individuals who had either OI or EB alone.
Histologic examination of an iliac crest sample from
R06-113A showed loss of normal orientation of the
lamellae (Figure 3). The lamellae were thinner than normal
and a pattern resembling ﬁsh scales was observed in some
areas under polarized light.
A second family (R93-188), originating from Mexico
(Family 6, Figure 1), with severe progressive deforming
OI in three affected siblings, was also identiﬁed. They
were included in the analysis because no mutations had
been identiﬁed in COL1A1, COL1A2, CRTAP, or LEPRE1.
They did not have any manifestations of EB. At the time
of ascertainment, the affected individuals were 12, 16,554 The American Journal of Human Genetics 86, 551–559, April 9, 2010and 18 years of age. Their respective
heights were 109, 124, and 132 cm
(<5th percentile). The two older
siblings were wheelchair bound,
whereas the younger child walked
with assistance. All three siblings had
short trunks resulting from severe
kyphoscoliosis, and additionally hadcoxa vara and extensive hyperextensibility of their joints,
especially the elbows and ﬁngers. They had neither denti-
nogenesis imperfecta nor hearing loss. Radiographic evalu-
ation demonstrated severe osteopenia, wormian bones,
scoliosis, and wedge vertebrae (Figure 2).
Homozygosity Mapping Identiﬁes a New OI Locus
EB simplex was conﬁrmed histologically by absence of
keratin 14, and a previous report in one case14 (Family 3,
Figure 1) demonstrated that the affected individual was
homozygous for a null mutation in the keratin 14 gene
(KRT14 [MIM 148066]). Analysis of DNA from all of the
Turkish affected individuals demonstrated that all were
homozygous for the previously identiﬁed c.612T>A
KRT14mutation predicted to lead to the amino acid substi-
tution Y204X (data not shown). Because all of the affected
individuals from the Turkish cohort segregated both EB
and OI, under the hypothesis that there were two recessive
disorders cosegregating in these families, the KRT14 region
on chromosome 17q21 became a candidate region for the
OI disease gene. Analysis of markers at loci near KRT14
identiﬁed a 0.83 Mb region of homozygosity between
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Figure 4. FKBP10 Mutation Detection
(A and B) Sequence analysis of exon 2 in control and a representative affected individual (R06-113A) with the mutation in the Turkish
families.
(C and D) Exon 5 sequence analysis in control and a representative affected individual (R93-188A) with the mutation in the Mexican-
American family (R93-188A).
(E) RT-PCR of FKBP10 cDNA from control and R06-113A ﬁbroblasts showing that a FKBP10 cDNA is synthesized.
(F) RT-PCR of FKBP10 cDNA from control and R93-188A ﬁbroblasts showing that a FKBP10 cDNA is not synthesized; lower band demon-
strates control cDNA synthesis.
(G) Cartoon of the FKBP65 molecule with predicted protein consequences for eachmutation. PPIase, peptidyl-prolyl cis-trans isomerase;
EF/Hand domain; HEEL, putative ER-retention sequence.39.63 and 40.46 Mb containing 38 genes (Genome Refer-
ence Consortium Human Build 37), one of which was
presumed to contain the OI mutation.
Mutations in FKBP10 Cause Recessive OI
Mutation analysis was carried out for two genes in the
interval, NKIRAS2 and FKBP10. NKIRAS2 screening was
negative but mutations were found in FKBP10. The
FKBP10 gene (MIM 607063), which encodes FKBP65, a 65
kD rough ER FK506-binding protein that is part of a large
family of FKBPs that have been implicated in a variety of
cellular processes that include peptidyl-prolyl cis-trans
isomerization (PPIase) and chaperone function, was among
the genes in the interval.16–18 KRT14 and FKBP10 are sepa-
rated by about 230,000 bp. Mutation analysis in one of the
Turkish cases (R06-113A) demonstrated homozygosity for
a 33 base pair deletion (c.321_353del) in FKBP10, which
is predicted to result in deletion of 11 amino acids, p.
Gly107_Leu117del, in the ﬁrst PPIase domain of the mole-
cule (Figuress 4A, 4C, and 4G). All affected Turkish individ-
uals were shown to be homozygous for the samemutation,The Amconsistent with a founder mutation in the population.
RT-PCR products derived from ﬁbroblasts of case R06-
113A showed that this mutation leads to synthesis of
FKBP65 mRNA containing the deletion (Figure 4E).
In the Mexican-American family, all affected individuals
were homozygous for a c.831_832insC sequence change
producing a translational frameshift (p.Gly278ArgfsX295)
predicted to result in a stop codon 17 amino acids down-
stream in the third PPIase domain of the protein (Figures
4B, 4D, and 4G). RT-PCR performed on mRNA obtained
from skin ﬁbroblasts from an affected individual showed
absence of FKBP65 cDNA, demonstrating that the muta-
tion leads to a functional null allele (Figure 4F). Neither
of the two mutations was found in panels of 210 alleles
from ethnically matched unaffected individuals, indi-
cating that they are not common polymorphisms in their
respective populations.
FKBP10 Mutations Affect Type I Collagen Synthesis
Because FKBP65 is known to localize to the ER,8 tandem
mass spectrometry was used to examine the possibilityerican Journal of Human Genetics 86, 551–559, April 9, 2010 555
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Figure 5. Type I Procollagen/Collagen Biochemical Analysis
(A) Cells synthesized normal procollagenous proteins. Normal amounts and mobilities were seen for proa1(I) and proa2(I) chains in
control and affected ﬁbroblasts in both the cell layer and the media (R06-016A, Family 3; R93-188A and B, Family 6).
(B) Cells also synthesized normal collagenous proteins, with normal amounts and mobilities seen for a1(I) and a2(I) chains in control
and affected ﬁbroblasts in both the cell layer and the media (R06-016A, Family 3; R93-188A and B, Family 6).that it could be functionally involved in the P3H1/CRTAP/
cyclophilin B complex and prolyl-3-hydroxylation.5 These
studies showed normal 3-hydroxylation of proline residue
986 (data not shown), indicating that the mechanism of
disease in this form of OI is distinct from that affecting
prolyl-3-hydroxylation.
To examine the effect of the mutations on type I procol-
lagen synthesis, cultured ﬁbroblasts from one of the
Turkish cases (R06-016A) and two of the Mexican-Amer-
ican siblings (R93-188A and R93-188B) were studied. In
all three cases, type I procollagens and collagens showed
normal electrophoretic migration on denaturing SDS-
PAGE gels, with no evidence of increased posttranslational
modiﬁcation (Figure 5). These data suggested that the type
I procollagen molecules synthesized by cultured mutant
cells in vitro folded in a similar fashion as compared to
molecules synthesized by normal cells. However, transmis-
sion electron microscopy demonstrated dilation of the ER
in cultured ﬁbroblasts from the affected individuals rela-
tive to control cells (Figure 6A), suggesting a defect in
protein secretion. To determine whether this represented
a defect in the intracellular processing of mature type I
procollagen, pulse chase studies were carried out and
showed a delay in the secretion of trimeric procollagen
in the cells from affected individuals in both families
compared to the control cells (Figures 6B and 6C).556 The American Journal of Human Genetics 86, 551–559, April 9, 2FKBP65 and Type I Procollagen Colocalize in the ER
FKBP65 is a known chaperone for type I procollagen.19,20
Confocal analysis of the intracellular distribution of
FKBP65 by immunoﬂuorescence showed that FKBP65
and type I procollagen colocalized in the ER in control
ﬁbroblasts (Figures 7A and 7B). Analysis of type I procolla-
gen in cultured ﬁbroblasts from individuals with the pre-
dicted in-frame deletion (R06-113A) and the null mutation
(R93-188A) of FKBP10 showed that type I procollagen
appeared to accumulate in aggregates within the cells,
especially in the FKBP65 null cells (Figures 7C and 7D).Discussion
Biosynthesis andmaturation of type I procollagen involves
a large number of posttranslational steps involving many
RER-resident proteins. Together these molecules mediate
disulﬁde bond formation, peptidyl-prolyl cis-trans isomeri-
zation, prolyl and lysyl hydroxylation, and hydroxylysyl
glycosylation. Molecular chaperones guide and provide
quality control for these processes as they interact with
the folding chains to prevent premature aggregation and/
or nonspeciﬁc interactions.8,10 Some chaperones, in-
cluding HSP47 and prolyl-4-hydroxylase, are collagen
speciﬁc,21,22 whereas others including calnexin, BiP,010
Figure 6. Transmission Electron Microscopy, Pulse-Chase of Collagenous Proteins
(A) TEM of cultured ﬁbroblasts from WT and an affected individual (R06-113A) showing dilated ER in the affected cells (labeled).
(B) Pulse-chase. The bands in each set represent the collagen trimers that migrated into the gel under nonreducing conditions. In all cell
lines, label was seen in the monomeric proa chains. For controls, by 40 min the amount of trimer in the medium exceeded that remain-
ing in the cells. In R06-113 and R93-188 cells, the amount in the medium exceeded that in the cells by 40 min of chase, but not to the
extent seen in control cells. In all experiments, the amount of labeling in the cells with FKBP10mutations was slightly reduced compared
to that in the control cells.
(C) Graph of band intensities from each pulse-chase experiment (control, R06-113A, and R93-188A) showing a delay in secretion of the
type I collagen trimer.GRP94, and PDI are general ER chaperones.21 ER chaper-
ones including HSP47 travel with type I procollagen from
the ER to the cis-Golgi, which facilitates the exit of mature
proteins from the ER for transport through the Golgi
apparatus, with HSP47 and procollagen dissociating
between the post-ER and cis-Golgi networks.23
The RER-localized FK506-binding protein FKBP65 is part
of a family of FKBPs that have been implicated in cellular
processes that include peptidyl-prolyl cis-trans isomeriza-
tion and chaperone functions. FBKP65 has some PPIase
activity that may assist in the folding of the proline-rich
tropoelastin monomer.24 Although the PPIase activity of
FKBP65 alone on collagen triple helix formation is
marginal,16 in vitro studies have demonstrated the ability
of FKBP65 to interact with the collagen triple helix and
function as a chaperone.19 Dilation of the ER in FKBP65-
related OI, along with delayed type I procollagen secretion,
is consistent with a defect in this process. The well-estab-
lished chaperone HSP47 is known to preferentially bind
to the triple helix of type I procollagen, rather than to
the unfolded chains. Evidence from HSP47 null cells
demonstrates that in the absence of a chaperone, type IThe Amprocollagen aggregates in the ER and there is deﬁcient
extracellular ﬁbrillogenesis.25 Similar to the HSP47 null
cells, the data presented here show aggregated intracellular
type I procollagen in FKBP65 mutant cells, suggesting a
functional defect in the chaperone activity of the FKBP65.
The OI phenotype resulting from FKBP65 deﬁciency was
consistent among the patients studied to date and charac-
terized by severe osteopenia, with fractures that began in
infancy and led to long bone deformities during child-
hood that prevented ambulation. Progressive kyphoscolio-
sis with platyspondyly and wedging of especially the
thoracic vertebrae was a consistent and distinctive ﬁnding
in this form of OI. Dentinogenesis imperfecta was absent,
hearingwasnormal, andblue sclerae,which is characteristic
of some types of OI because of mutations in the type I pro-
collagen genes, was not present. Because of the moderately
severe and progressive nature of the phenotype, FKBP65-
related OI most closely resembles OI type III. However, the
phenotype does not ﬁt neatly into this category and the
histological features, with a distorted lamellar structure
and a ﬁsh scale-like pattern, alongwith elevated serumalka-
line phosphatase, was also similar to OI type VI.4,26erican Journal of Human Genetics 86, 551–559, April 9, 2010 557
Figure 7. Intracellular Localization of FKBP65 and Type I Procollagen
(A–C) Confocal microscopy demonstrating ER localization of both FKBP65 (green) and type I procollagen (red) and colocalization of the
two proteins in control ﬁbroblasts and R06-113 (merge).
(C and D) Confocal microscopy of ﬁbroblasts from cases R06-113A and R93-188A, respectively, demonstrating a speckled pattern of type
I procollagen suggestive of intracellular aggregates containing this protein.Among the Turkish cases, all of the families studied were
derived from cities in the eastern Black Sea region and all
affected individuals had a second recessive disorder, EB
simplex. This strongly suggested a founder effect, an infer-
ence supported by the conserved disease haplotype among
the families and the identiﬁcation of homozygosity for
both the KRT14 EB simplex mutation and the FKBP65 OI
mutation among all of the affected individuals. A case of
EB simplex resulting from the same Y204X mutation in a
girl from the Black Sea region of Turkey in whom OI was
not present suggests that the FKBP10 mutation occurred
on an allele carrying the KRT14 EB mutation.27
At least three distinct mechanisms are now known to
produce OI. Primary defects in the type I procollagen genes
that lead to reduced synthesis and/or abnormal structure
of type I collagen produce the vast majority of OI cases,
most of which are dominantly inherited. Defects in post-
translational modiﬁcation of type I procollagen resulting
from loss of the prolyl-3-hydroxylation complex have
been found in a proportion of recessively inherited severe
to lethal OI cases.5,12 In the present study, abnormalities
in type I procollagen chaperone activity, resulting from
defects in the FKBP65, have been identiﬁed in amoderately
severe form of OI. Despite the different OI inheritance
patterns and diverse molecules involved in these disorders,558 The American Journal of Human Genetics 86, 551–559, April 9, 2the unifying principle among all of the forms of OI appears
to be abnormalities that affect the synthesis, assembly, and
secretion of mature type I collagen to form the template
necessary for normal bone mineralization.Acknowledgments
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